CLOs on the Move

NeuBase Therapeutics

www.neubasetherapeutics.com

 
NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington`s disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been “undruggable.” for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase`s pipeline includes
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Alan Scrivner
 VP, Legal and Intellectual Property Profile

Similar Companies

SunMed

Select SunMed for Anesthesia and Respiratory Care SolutionsDedicated to Improving Quality of LifeWho Is SunMedSelect SunMed for Your Place to GrowDedicated to Improving Quality of LifeCareers with SunMedSelect SunMed for Medical Device ManufacturingDed...

Evotec

Evotec is a Winchester, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Collegium Pharmaceutical

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company focused on becoming the leader in responsible pain management by developing and commercializing innovative, differentiated products for patients suffering from pain.

Fairfax Behavioral Health

OmegaChem

OmegaChem is a Levis, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.